Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Pathward Financial
CASH
$1.8B
| $46.2M | ﹤0.01% |
699,884
+18,936
| +3% | +$1.22M |
|
|
VSXY
1477
Victoria's Secret
VSXY
$7.83B
| $46.1M | ﹤0.01% |
1,794,221
+24,967
| +1% | +$529K |
|
1478
Sotera Health
SHC
$5.38B
| $46M | ﹤0.01% |
2,755,391
+447,186
| +19% | +$6.53M |
|
1479
Federated Hermes
FHI
$4.72B
| $46M | ﹤0.01% |
1,250,182
+92,643
| +8% | +$3.17M |
|
1480
Flywire
FLYW
$2.16B
| $45.9M | ﹤0.01% |
2,799,486
+17,062
| +0.6% | +$298K |
|
1481
Enterprise Financial Services Corp
EFSC
$2.39B
| $45.7M | ﹤0.01% |
892,030
+8,180
| +0.9% | +$402K |
|
|
THS
1482
DELISTED
Treehouse Foods
THS
| $45.7M | ﹤0.01% |
1,088,330
-21,244
| -2% | -$843K |
|
1483
Chewy
CHWY
$9.63B
| $45.4M | ﹤0.01% |
1,550,844
+119,633
| +8% | +$3.19M |
|
1484
Extreme Networks
EXTR
$3.15B
| $45.4M | ﹤0.01% |
3,018,966
-312,825
| -9% | -$4.43M |
|
1485
Cheesecake Factory
CAKE
$5.33B
| $45.4M | ﹤0.01% |
1,118,549
+12,493
| +1% | +$475K |
|
1486
Globant
GLOB
$1.61B
| $45.3M | ﹤0.01% |
228,855
-4,107
| -2% | -$794K |
|
1487
FirstService
FSV
$6.32B
| $45.1M | ﹤0.01% |
240,603
+10,213
| +4% | +$1.76M |
|
|
AKRO
1488
DELISTED
Akero Therapeutics
AKRO
| $45.1M | ﹤0.01% |
1,571,012
-48,027
| -3% | -$1.25M |
|
1489
NeoGenomics
NEO
$2.13B
| $45M | ﹤0.01% |
3,051,806
+36,136
| +1% | +$565K |
|
|
QXO
1490
QXO Inc
QXO
$17.4B
| $45M | ﹤0.01% |
2,853,653
+2,849,269
| +64,992% | +$83.1M |
|
1491
Concentrix
CNXC
$1.57B
| $45M | ﹤0.01% |
878,092
+43,295
| +5% | +$2.9M |
|
1492
Amphastar Pharmaceuticals
AMPH
$916M
| $44.7M | ﹤0.01% |
920,363
+14,015
| +2% | +$615K |
|
|
HI
1493
DELISTED
Hillenbrand
HI
| $44.6M | ﹤0.01% |
1,602,744
+6,682
| +0.4% | +$235K |
|
1494
TTM Technologies
TTMI
$14.5B
| $44.5M | ﹤0.01% |
2,437,400
+30,738
| +1% | +$593K |
|
1495
Gulfport Energy Corp
GPOR
$2.88B
| $44.5M | ﹤0.01% |
293,882
+34,909
| +13% | +$5.12M |
|
1496
Vera Therapeutics
VERA
$2.36B
| $44.4M | ﹤0.01% |
1,004,665
+20,223
| +2% | +$767K |
|
1497
iShares MSCI Taiwan ETF
EWT
$10.7B
| – | – |
0
| – | – |
|
1498
NCR Voyix
VYX
$1.14B
| $44.3M | ﹤0.01% |
3,266,734
+86,709
| +3% | +$1.16M |
|
1499
Veeco
VECO
$3.23B
| $44.3M | ﹤0.01% |
1,337,321
+22,850
| +2% | +$856K |
|
1500
Beam Therapeutics
BEAM
$2.84B
| $44.3M | ﹤0.01% |
1,807,683
+78,102
| +5% | +$2.02M |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.